CMDh News – February 2016
07.03.2016
more
Medicinal Products
CHMP News – February 2016
29.02.2016
more
Beginning of a review of medicines containing dienogest 2 mg and ethinylestradiol 0.03 mg when used for acne
29.02.2016
more
EMA confirms recommendations to minimise risk of brain infection PML with Tysabri
29.02.2016
more
EMA confirms recommendations to minimise ketoacidosis risk with SGLT2 inhibitors for diabetes
29.02.2016
more
Measures for additional protection of patients from falsified medicinal products based on the Commission Delegated Regulation (EU) 2016/161 and plans for introduction of new safety features
19.02.2016
more
PRAC News – February 2016
15.02.2016
more
Updated recommendations to minimise the risk of the rare brain infection PML with Tysabri
15.02.2016
more
SGLT2 inhibitors: PRAC makes recommendations to minimise risk of diabetic ketoacidosis
15.02.2016
more
CMDh News – January 2016
05.02.2016
more
